Considering that PD-L1, sporting the guise of immune cell membranes, coalesces with PD-1 to curtail the activation and cytotoxic prowess of the same towards neoplastic cells, a surge in PDIA3 could champion the veiling of tumor entities from immune surveillance. The gene discussed is CD274; the disease is neoplasm.